Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
J Neurosci. Author manuscript; available in PMC 2014 February 27.
Published in final edited form as:
PMCID: PMC3936607

β-secretase cleavage of the fly Amyloid Precursor Protein is required for glial survival


β-secretase (or BACE1) is the key enzyme in the production of β-amyloid (Aβ), which accumulates in the senile plaques characteristic for Alzheimer's Disease (AD). Consequently, the lack of BACE1 prevents β-processing of the Amyloid Precursor Protein (APP) and Aβ production, which made it a promising target for drug development. However, the loss of BACE1 is also detrimental, leading to myelination defects and altered neuronal activity, functions that have been associated with the cleavage of Neuregulin and a voltage-gated sodium channel subunit. Here we show that the Drosophila orthologue of BACE, dBACE, is required for glial survival. Cell-specific knockdown experiments reveal that this is a non-cell autonomous function, as a knockdown of dBACE in photoreceptor neurons leads to progressive degeneration of glia in their target zone, the lamina. Interestingly, this phenotype is suppressed by the loss of the fly Amyloid Precursor Protein (APPL), whereas a secretion-deficient form of APPL enhances the degeneration. This shows that full-length APPL in neurons promotes the death of neighboring glial cells and that β-processing of APPL is needed to prevent glial death. These results therefore not only demonstrate a novel function for an APP protein in glia, but they also show this function specifically requires regulation by β-cleavage.


BACE1 (β-site amyloid precursor protein cleaving enzyme 1) was identified by several groups as the secretase that cleaves the Amyloid Precursor Protein (APP) at the N-terminal Aβ site (Hussain et al., 1999; Sinha et al., 1999; Vassar et al., 1999; Yan et al., 1999; Lin et al., 2000), the first step in generating Aβ. Therefore, BACE1 plays an important role in amyloid plaque formation, which occurs in the brains of patients with Alzheimer's Disease (AD). BACE1 is an aspartic protease that is ubiquitously expressed, but the highest levels are found in neurons and the pancreas (Mowrer and Wolfe, 2008). In contrast, its homolog BACE2 is only weakly expressed in neurons and, at least under physiological conditions, does not appear to be involved in Aβ production (Bennett et al., 2000; Yan et al., 2001; Fluhrer et al., 2002). Loss of BACE1 in transgenic mice models of AD prevents Aβ production and APP-induced phenotypes (Luo et al., 2001; Laird et al., 2005; Ohno et al., 2007). However, APP is not the sole substrate of BACE1; since its identification, several other substrates have been described, including Neuregulin 1 and the β-subunit of a voltage-gated sodium channel (Willem et al., 2009).

The first BACE1 knockout mice were described as healthy and fertile with no obvious phenotype (Cai et al., 2001; Roberds et al., 2001). However, later subtle defects were described in these animals, including smaller size, increased mortality within the first week, and being timid and less exploratory (Harrison et al., 2003; Dominguez et al., 2005). Eventually, it was reported that the loss of BACE1 caused a delay in myelination and thinner myelin sheaths in the central and peripheral nervous system, an effect that was attributed to the lack of Neuregulin 1 cleavage (Hu et al., 2006; Willem et al., 2006). In addition, it was described that the loss of BACE1 altered neuronal activity and synaptic plasticity accompanied by a decrease in cognitive performance and seizures, probably due to the effects of BACE1 on sodium channels (Laird et al., 2005; Wang et al., 2008; Hu et al., 2010; Kim et al., 2010).

We recently demonstrated that Drosophila also expresses a protein with β-secretase activity that cleaves the fly APP protein APPL (Amyloid Precursor Protein-like). This protein, which we called dBACE, shows about 50% sequence similarity to human BACE1 and BACE2 with significantly higher conservation in the regions containing the active site aspartates (Carmine-Simmen et al., 2009). We also showed that dBACE can cleave APPL, generating an alternative C-terminal fragment (CTF) to the predominant β-cleaved CTF. Furthermore, overexpression of dBACE enhanced the histological and behavioral phenotypes caused by APPL. Together with our results that a fly Aβ-like fragment derived from APPL is neurotoxic, this suggests that fly dBACE and its vertebrate orthologues have similar functions. We now describe that the neuronal knockdown of dBACE results in glial cell death, a function that is mediated by the lack of APPL cleavage.

Materials and Methods

Drosophila stocks

UAS-APPL and UAS-dBACE were previously described in Carmine-Simmen et al. (2009). GMR-GAL4, elav-GAL4, repo-GAL4 (M1B), act5-GAL4, tubP-GAL4, Df (2L)Exel7038 and Df(2L)N22-14 were obtained from the Bloomington Stock Center. UAS-APPLSD flies were a gift from Vivian Budnick (University of Massachusetts, Worcester), and the Appld flies were kindly provided by Kalpana White (Brandeis University, MA). Appl-Gal4 was obtained from Laura Torroja (Universidad Autonoma de Madrid, Spain) and UAS-dBACERNAi from the Vienna Drosophila RNAi Center (Vienna, Austria). dBACE point mutations were provided by the Drosophila TILLING Project. dBACE-Gal4 was constructed from a 5.2kb fragment from BAC CH322-91L18. This construct, which includes 4.5kb of the sequence upstream from the predicted dBACE start site was cloned into the pPTGAL vector. Fly lines carrying this construct were created by P-element transformation using Best Gene Inc. (Chino Hills, CA). The N-terminal sAPPL fragment and the APPL-AICD were described in Wentzell et al. (2012). Flies were raised under standard conditions at 25°C.

Quantitative RT-PCR

RNA was extracted from Drosophila as described by the DGRC (Bogart and Andrews, 2006) using Trizol (Invitrogen). Residual genomic DNA was degraded with DNaseI (Fermentas), and the cDNA was synthesized following the protocol of the SuperScript III Reverse Transcriptase Kit using oligo(dT)12-18 primer (Invitrogen). The qPCR reaction was performed as recommended in the SYBR Green PCR Master Mix Kit (Applied Biosystems) and analyzed on a Bio-Rad iCycler iQ. As primers, we used CAAGACCATCGCTGTAGTAGTGCT and TCTGACGCGTCTTCACAAAG for dBACE and GCGGCAGCTACAACACAATA and CATCATTACCAGGGCGAAAT for the control reaction using the swiss-cheese gene. Because it has been described that the levels of dBACE are decreased 2.9 fold in response to mating (McGraw et al., 2004), we only used virgin females for this and all the other analyses. Fold changes were calculated using the Pfaffl method (Pfaffl, 2001).

Tissue sections for light microscopy and electron microscopy

Paraffin sections for light microscopy were prepared as described in Bettencourt da Cruz et al. (2005). Briefly, whole flies were fixed in Carnoy and dehydrated in an ethanol series, followed by methyl benzoate. Sections were cut at 7μm and imaged, using the autofluorescence caused by the eye pigment. For electron microscopy, ultrathin Peon plastic sections were prepared as described in Kretzschmar et al. (1997) and analyzed with a FEI Morgagni 268 electron microscope.

Measurement of the vacuolar pathology

To analyze the neurodegenerative phenotype of different genotypes, we took images from the lamina at the level of the first optic chiasm. For a double blind analysis, pictures were analyzed without knowing the genotype, and numbered. To account for size differences of the flies, we determined the area occupied by the vacuoles and presented it as a percentage of the area of the entire lamina (cortex and neuropil) in each brain hemisphere. Areas were calculated in Photoshop as total pixel number, and the analysis completed after revealing the genotypes. As controls, we used sibling flies from the same cross, which only carried the UAS or GAL4 construct to minimize genetic background effects. Statistics were done using one-way ANOVA and a Dunett's post-test in cases where several experimental groups were compared to one control group. Student Newman-Keuls tests were used when only comparing two groups.


Vibratome sections of fly heads were prepared as described in Drobysheva et al. (2008). After being fixed overnight in 4% paraformaldehyde and embedded in 3% agar, heads were cut on a Vibratome Series 1000 Sectioning System at a thickness of 50μm. Sections were stained with anti-REPO (1:5) and 22C10 (1:25), obtained from the Developmental Studies Hybridoma Bank. Anti-Cleaved Caspase-3 (Cell Signaling) was used at 1:50, anti-GFP (Clontech) at 1:250, and anti-APPL-CTF (a gift from Philip Copenhaver, OHSU) at 1:100. Anti-dBACE was raised in rabbits against a synthetic peptide containing amino acids 41-59 of the dBACE coding sequence by Davids Biotechnologie (Regensburg, Germany) and used at a dilution of 1:500. When performing single antibody stainings, we used a biotinylated secondary antibody (1:200 Vector Labs) and a Cy5 Conjugated Strepavidin (1:100 Jackson ImmunoResearch). In the case of the double labeling with dBACE, dBACE immunoreactivity was detected using Cy2 (1:1000 Jackson ImmunoResearch) and the second protein of interest was visualized with the biotin-Cy5-Strepavidin enhancement. In the case of the anti-Caspase and anti-REPO double staining, the REPO immunoreactivity was enhanced with biotin-Cy5-Strepavidin. All washes were performed with PBS+ 0.1% Triton-X (PBST), and antibody dilutions were in PBST + 2% Goat serum (Vector Laboratories). For the detection of the endogenous expression pattern of dBACE, we used y1w1118 to minimize interference by the autofluorescence from the eye pigment. Images were taken on an Olympus FW1000 confocal microscope.

Western Blots

Western Blots were performed as described in Carmine-Simmen et al. (2009). For dBACE, lysates from10 heads were loaded on 8% SDS gels, blotted onto PVDF membranes (Amersham Biosciences), and dBACE detected using our anti-dBACE antisera at a dilution of 1:2000. For detection of APPL and its C-terminal fragments, fresh lysates from 10 heads were loaded on a precast 10-20% Criterion Tris-HCL Gel (BioRad), and APPL detected using the anti-APPL-CTF antibody at 1:2000. For loading controls, we used anti-beta-Tubulin (E7; DSHB) at 1:250. Secondary HRP-conjugated antibodies were used at 1:10,000 (Jackson Laboratories). dBACE and Tubulin bands were visualized using the Western Lightning Chemiluminescent Reagent Plus (Perkin Elmer). APPL-CTF fragments were visualized with SuperSignal West Femto Chemiluminescent Substrate (Thermo Scientific). For the analysis of endogenous full length APPL, samples from 5 heads were run on 7.5% gels and APPL detected with anti-C-term APPL. Quantification of the protein levels was done with the Odyssey infrared image system from LI-COR. LI-COR IRDye secondary antibodies were used at a dilution of 1:10,000 in LI-COR Blocking Buffer. Full-length APPL and CTF fragments were analyzed separately to optimize the conditions for their detection by Western Blot analysis.

Fast phototaxis and survival

Fast phototaxis assays were conducted in the dark using the countercurrent apparatus described by Benzer (1967) and a single light source. A detailed description of the experimental conditions can be found in Strauss and Heisenberg (1993). Flies were starved overnight but had access to water and were tested the following morning. Five consecutive tests were performed in each experiment, with a time allowance of 6 seconds to make a transition towards the light and into the next vial. A minimum of 200 females, in groups of 15-25 flies, was used per age and genotype and at least 12 independent tests were performed for each condition. For aging, flies were transferred to fresh vials every 4-5d. ANOVA was applied to data sets of a given age to reveal significant differences. A Student Newman-Keuls test was used to identify the significantly different groups. For the survival assay, a total of 1322 female flies were used for elav-GAL4; UAS-APPL, and a total of 1196 for elav-GAL4; UAS-APPL in the dBACE5243 background. Flies were kept in groups of 30-50 flies, and the vials exchanged every 4-5d. ANOVA and Student Newman-Keuls tests were used for statistical analysis.


Loss of dBACE results in lethality during development

To obtain mutants for dBACE, we used the Tiling Project (Winkler et al., 2005), which identified 14 lines that carried amino acid-changing point mutations in the open reading frame of dBACE. For our analysis, we focused on three of these lines where the amino acid changes were predicted to have functional consequences; dBACE5243, which contains a substitution of P190 to L, dBACE2045 (R21 to G and N63 to I), and dBACE2525 (S207 to L). Crossing these lines with a deficiency, Df(2L)N22-14, that deletes the chromosomal region containing dBACE (29D2), produced viable and fertile progeny in the case of dBACE2045 and dBACE2525. In contrast, no adults eclosed with dBACE5243, a result that was later confirmed with a smaller deficiency, Df(2L)Exel7038, after it became available. This suggests that dBACE2045 and dBACE2525 are hypomorphic allele. This was supported by a Western Blot analysis, which showed a slight reduction in dBACE levels in dBACE2045 and no change in dBACE2525 (Fig. 1A; lane 2 and 4). In contrast, heterozygous dBACE 5243 (carried over the CyO balancer; lane 5) showed a clear reduction in dBACE levels (between 40% and 60%, from 3 experiments), suggesting that the dBACE 5243 allele expresses little or no dBACE, consistent with this allele being a null or strong hypomorph.

Figure 1
dBACE mRNA and protein levels. (A) Western Blot using an anti-dBACE serum shows expression of the approximately 38kD dBACE protein in head extracts from wild type flies (lane 1 and 3). Neither dBACE2045 (lane 2) nor dBACE2525 (lane 4) show significant ...

The requirement of dBACE during development was also confirmed by an RNAi-mediated knockdown of dBACE. Inducing the RNAi-construct ubiquitously with the tubP-GAL4 promoter resulted in complete lethality during the late-larval/early pupal stage. Inducing the RNAi with Act5-GAL4 also resulted in the death of most animals in these stages, although a few females survived into adulthood. Quantitative RT-PCR analysis of these females showed an almost complete loss (39-fold decrease) of the dBACE mRNA, compared to control flies carrying only the RNAi construct or the Act5-GAL4 promoter constrruct (Fig. 1B). To verify that this lethality is due to reductions in dBACE levels, we performed a rescue experiment co-expressing either UAS-dBACE or UAS-GFP in tubP-GAL4/UAS-dBACERNAi flies. Whereas still no animals survived into adulthood with UAS-GFP (showing that the addition of a second UAS construct did not reduce the lethal effect of the UAS-RNAi construct), expression of UAS-dBACE partially rescued the lethality, with 35% of female flies eclosing.

dBACE is required for the integrity of the lamina

To determine whether dBACE mutants have an effect on the nervous system, we examined paraffin head sections from flies expressing the dBACE RNAi pan-neuronally (via Appl-GAL4). Whereas newly eclosed flies did not show a detectable phenotype (data not shown), flies aged for four weeks showed vacuoles in the lamina cortex (arrowheads, Fig. 2B and Fig. 2F) and a few scattered holes in the central brain (Table 1). A knockdown of dBACE in the retina using GMR-GAL4, which was confirmed by Western blots (Fig. 1C), induced a very similar degeneration in the lamina cortex (Fig. 2C). Again, the phenotype was progressive, with significantly more vacuolization in 28d-old flies compared to 3d or 14-day-old (Fig. 2G; 3d-old flies were not significantly different from controls). Interestingly, although the phenotype was more severe in the GMR-mediated knockdown (Fig. 2F), with vacuoles present along the entire lamina cortex resulting in an almost complete separation of the lamina cortex from the basement membrane (white lines in magnifications in Fig. 2), we did not detect vacuoles in the lamina neuropil or any other brain areas. This suggests, a non-cell autonomous effect of the dBACE knockdown in photoreceptors on cells in the lamina cortex indicating that the phenotype is due to the disruption of an interaction between photoreceptor axons and cells localized in the lamina cortex. The degenerative phenotype in the lamina cortex was also confirmed in 28-day-old dBACE mutants. Both dBACE2525 and dBACE2045 showed degeneration in the lamina when in trans with the lethal dBACE5243 allele (dBACE2045/dBACE5243 and dBACE2525/dBACE5243) although the phenotype was significantly less severe in dBACE2525 than dBACE2045, suggesting that dBACE2045 is a stronger hypomorph (Fig. 2H). In contrast to the retinal dBACE knockdown, dBACE2045/dBACE5243 and dBACE2045/Df(2L)Exel7038 deficiency flies also exhibited small vacuoles in the lamina neuropil and in the central brain (arrow, Fig. 2D, E, H, Table 1). The occurrence of vacuoles outside the lamina cortex in these genotypes (and the pan-neuronal knockdown of dBACE) suggests that the general loss of dBACE can affect the interactions of neurons with neighboring cells in many brain regions, whereas the eye-specific knockdown only interferes with the interaction between photoreceptors and cells in their target field. A summary of the statistical data is shown in Table 1.

Figure 2
dBACE mutant and knockdown flies show degeneration in the lamina. (A) GMRGAL4 control flies show an intact lamina neuropil (la n), which mostly consists of neuronal fibers, and lamina cortex (la c), which houses the cell bodies of the neuronal monopolar ...
Table 1
Summary of the degeneration measurements. Note that even wild type Canton S and the GMR-GAL4 and UAS-dBACERNAi flies show some vacuolization in the lamina cortex, possibly due to the presence of large trachea in this area which appear as vacuoles in the ...

The degeneration is rescued by dBACE expression in neurons

To verify that the degenerative phenotype was due to an effect on dBACE, we co-expressed UAS-dBACE with the dBACERNAi construct in the dBACE mutant. As controls, we analyzed sections from four-weeks-old flies that express only UAS-dBACE via GMR-GAL4 and found that the strong overexpression of dBACE (lane 1; Fig. 1C) also resulted in vacuole formation in the lamina (and the retina). These vacuoles, however, were distributed more randomly (arrows, Fig. 3B) and were not restricted to the lamina cortex as seen in the dBACERNAi flies. In addition, these vacuoles were quite large, comparable the vacuoles described in APPL or dAβ overexpressing flies (Carmine-Simmen et al., 2009). Because we previously showed that dBACE co-expression enhances APPL-induced phenotypes (Carmine-Simmen et al., 2009), we assume that these large vacuoles are due to increased production of the toxic dAβ fragments when dBACE is overexpressed. We currently do not know the cellular mechanisms that result in the different types of vacuole formation; however, the large size of the vacuoles induced by overexpression of APPL/dAβ/dBACE could be due to the deleterious effects of a dying neuron on neighboring neurons and axons, possibly caused by the release of dAβ. Although expression of UAS-dBACE also resulted in vacuoles, we found that co-expressing it with UAS-dBACERNAi rescued the vacuolization in the lamina (Fig. 3G), with only some small vacuoles still detectable in the lamina cortex and/or lamina neuropil (arrows in Fig. 3C). In contrast, co-expressing UAS-GFP (as a control to account for the number of UAS constructs) had no effect on the dBACE knockdown phenotype (Fig. 3A). To confirm the rescue experiments, we also expressed dBACE in the dBACE2045 mutant over the Df(2L)Exel7038 deficiency. In addition to lesions in the lamina cortex, 4-week-old dBACE2045/Df(2L)Exel7038 flies show vacuole formation in the lamina neuropil (arrows, Fig. 3D) in 94% of the flies (n=39). We therefore used the pan-neuronal elav-GAL4 driver to achieve a more widespread expression of dBACE while minimizing overexpression phenotypes, (due to the lower expression levels induced by this promoter construct). As shown in figure 3E and H, we could significantly reduce the vacuolization in the lamina cortex and lamina neuropil. Finally, we used a dBace-GAL4 promoter construct we created by inserting 5.4kb of the upstream region of dBACE in front of the GAL4 promoter for rescue experiments. Using this promoter construct to express UAS-dBACE in dBACE2045/Df(2L)Exel7038 transheterozygotes resulted in a complete rescue, with as in wild type, only occasionally a few, very small vacuoles detectable (Fig. 3F, H). Together, these experiments verify that the loss of dBACE is indeed causing degeneration.

Figure 3
The degeneration is rescued by expressing dBACE. (A) A GMR-GAL4; UAS-dBACERNAi fly shows the characteristic row of vacuoles in the lamina cortex (arrowheads). (B) In flies overexpressing dBACE in photoreceptors we find vacuoles in the lamina neuropil, ...

Degeneration commences in the subretinal layer of the lamina cortex

To analyze these degenerative defects in more detail, we performed electron microscopic studies on brains from GMR-GAL4; UAS-dBACERNAi flies. Focusing on the lamina cortex (for orientation, see Fig. 4A and box in Fig. 4E), we found that at 24-32 hours post eclosion glial cells, monopolar neurons, and photoreceptor axons were present and seemingly unaffected (Fig. 4C). However, we could already detect some very small lesions close to the basement membrane (arrows). At a higher magnification (Fig. 4G), we found that these were due to a loosening of the tissue of the lamina cortex from the basement membrane (indicated by the arrowheads). In addition, finger like extensions from the basement membrane became visible in these areas (arrow, Fig. 4G). In 14-day-old knockdown flies, the vacuoles near the basement membrane were significantly larger (arrows, Fig. 4D), and the finger-like protrusions appeared more stunted (arrow, Fig. 4H). In addition, we found vacuoles in more proximal regions of the lamina cortex (white arrows, Fig. 4D), confirming the progressive nature of the degeneration. In contrast, 24-32h (data not shown) and 14-day-old GMR-GAL4 control flies (Fig. 4B, F) did not show any of these phenotypes. That the first lesions were detectable close to the basement membrane suggested that the first cells affected are cells that are localized in this subretinal layer.

Figure 4
Electron microscopy reveals a separation of the lamina cortex from the basement membrane. (A) Schematic of the lamina cortex (la c) region shown in (B) and where it is localized in the fly head (box in E). The retina (re) is separated from the lamina ...

dBACE is required for glial survival

The subretinal layer of the lamina cortex contains two types of glial cells but no neuronal cell bodies, which suggested that the degeneration is due to the death of glial cells. To verify effects on glia, we performed immunohistochemical stainings on GMR-GAL4;UAS-dBACERNAi flies, using the glial marker anti-REPO. Already in 3-day-old GMR-GAL4;UAS-dBACERNAi flies (Fig. 5B), we detected slight changes in the glial pattern when compared to 3d (data not shown) or 3-week-old control flies carrying only GMR-GAL4 (Fig. 5A; aging did not affect the glial pattern in controls). As seen in the control flies, rows of glial cells could be detected in the subretinal layer, (Fig. 5A, red arrow) which contains the fenestrated glia and the pseudocartridge glia (Kretzschmar and Pflugfelder, 2002; Edwards and Meinertzhagen, 2010). Slightly proximal to this layer, the outer satellite glia form a row on top of the neuronal monopolar cell bodies, whereas the inner satellite glia form a row proximal to the monopolar cells near the border to the lamina neuropil (arrowhead). In contrast to these glial types, the epithelial glia are positioned in the distal lamina neuropil (white arrow) and not in the lamina cortex. In comparison to the controls, anti-REPO staining in 3-day-old GMR-GAL4; UAS-dBACERNAi flies was weaker and a few gaps appeared in the glial rows in the subretinal layer (Fig. 5B, red arrows). The inner satellite glia and epithelial glia also seemed less intensely stained, but there were no obvious gaps (arrowhead and white arrow). In 3-week-old knockdown flies, only a few glial cells were detectable in the subretinal layer (Fig. 5C, red arrows). Most of the remaining glia in the lamina cortex appeared to be satellite glia (arrowheads), although the general disorganization made an identification of the affected subtypes difficult (and to the best of our knowledge, no subtype-specific markers are available). Counting the REPO immunopositive cells in these flies confirmed a significant reduction compared to controls with 11.9±0.9 positive cells in RNAi knockdown flies compared to 36.0±1.1 immunopositive cells in control flies only expressing GMR-GAL4 (p<0.001, with 9 experimental and 5 control flies analyzed). A similar loss of glial staining was detectable in 3-week-old homozygous dBACE2045 flies, which also showed gaps in the rows of the glia in the subretinal layer (Fig. 5D, red arrow). Even more prominent was the loss of epithelial glia, of which only a few remained (white arrow). As seen in the knockdown flies, the satellite glia (arrowheads) appeared to be least affected. In contrast to the glial staining, staining neurons (using anti-ELAV) did not reveal a difference between 3-week-old control and GMR; UAS-dBACERNAi flies (Fig. 5E, F). A quantitative analysis confirmed that there was no statistically significant difference in neuronal numbers between the knockdown and control flies (49±2.3 versus 45±1.8 immunopositive cells, with 9 experimental and 7 control flies analyzed) although we did find a few less ELAV-immunopositive cells (p=0.053). This minor decrease could be due to a weak direct effect of the photoreceptor knockdown on the lamina monopolar cells or to a secondary effect caused by the missing glial support at this stage.

Figure 5
Loss of glial staining in the dBACE knockdown and mutant. (A-D) 50μm vibratome head sections stained with anti-REPO. The image shows a stack of 10 confocal sections taken at 0.5μm steps. (A) In a 3-week-old GMR-GAL4 control fly, anti-REPO ...

To confirm that the decrease in REPO staining is in fact due to cell death, we used a Cleaved Caspase-3 antibody as a marker for apoptosis. As shown in Figure 6B, we could detect single immunopositive cells in the lamina cortex of 3-5 day old GMR; UAS-dBACERNAi knockdown flies (arrows and arrowheads) and many of these cells were localized close to the basement membrane at the position of the fenestrated glia and pseudocartridge glia (arrows in Fig. 6B, C). In contrast, almost no staining was detectable in controls only expressing GMRGAL4 (Fig. 6A). Counting Caspase-immunopositive cells confirmed that this difference was highly statistically significant with 0.8±0.4 positive cells (from 6 animals) in the controls compared to 13.2±0.8 in the knockdown flies (p<0.001, 9 animals). To determine the identity of the dying cells, we performed a double staining with anti-Cleaved Caspase-3 and anti-REPO. As shown in Figure 6D-F, all the Caspase-positive cells were also labeled with anti-REPO (arrows), verifying that the degenerating cells are glial cells. In addition, most of the dying glial cells were found close to the basement membrane, whereas more proximally localized glial cells were not positive for anti-Caspase-3 (arrowheads), supporting our observations from the electron microscopic studies that the glia in the subretinal layer are the first affected by the lack of dBACE.

Figure 6
Loss of dBACE causes apoptotic cell death of glia. (A,B) Vibratome sections stained with anti-Cleaved Caspase-3. (A) Whereas a 3-5d-old wild type control does not show any anti-Caspase staining (the weak green autofluorescence is caused by the eye pigment), ...

dBACE is expressed in neurons and axons

As described above, glial degeneration occurs when dBACE is knocked down in photoreceptors. To determine whether dBACE is endogenously expressed in neurons, including photoreceptor, we used our anti-dBACE antibody on tissue sections. Although we showed in Western Blots that this antibody does recognize dBACE, we verified its specificity on tissue sections by showing that the immunostaining was significantly reduced in a pan-neuronal knockdown of dBACE (using the Appl-GAL4 driver to induce dBACE RNAi) and almost completely absent in the few surviving females with the ubiquitous knockdown (via Act5C-GAL4; data not shown). We found that dBACE is expressed in the brain cortex (Fig. 7A, arrow), the optic neuropils (especially the lamina and medulla, arrowheads), and the neuropils of the central brain (Fig. 7B). This widespread expression in the cortex, which houses the neuronal cell bodies, suggests that dBACE is expressed in most or all neurons. To verify neuronal expression, we performed a double labeling experiment with the 22C10 antibody against the neuronal MAP1B orthologue Futsch (Hummel et al., 2000). Using 0.5μm thick confocal sections, we detected a significant overlap of 22C10 (red) and dBACE (green), including staining in the photoreceptor axons in the medulla (arrowheads, Fig. 7C), verifying a neuronal expression of dBACE.

Figure 7
dBACE is expressed in neurons. (A, B) Vibratome sections stained with anti-dBACE reveal expression in the brain cortex (arrow in A, stack of 25 0.5μm confocal sections) and in the neuropils of the optic system (arrowheads in A) and central brain ...

We also performed double labeling for dBACE and APPL to confirm that dBACE and its substrate co-localize. As previously shown, APPL (red) is expressed pan-neuronally (Luo et al., 1990) including the photoreceptor axons in the medulla (Fig 7D, arrows). As expected, we detected APPL and dBACE in overlapping compartments in the photoreceptor axons (Fig. 7D, arrows) as well as in neuronal cell bodies within the neighboring cortex region (arrowheads, Fig. 7D). This experiment not only confirmed the neuronal expression of dBACE but also revealed a significant co-localization with APPL. That this includes photoreceptors is further verified by the strong co-expression of both, APPL and dBACE, within the retina (Fig. 7E). Finally, we performed an experiment to determine whether dBACE is also expressed in glia. For this experiment, we induced expression of the membrane-bound mCD8-GFP with repo-GAL4 to label glial membranes. As shown in figure 7F, there was substantially less overlap of dBACE with this glial marker compared to the neuronal markers. Due to the close association of glial processes with neurons, we could not distinguish whether this apparent double labeling is indeed due to co-localization in some glial cells or to labeling in neurons and their adjacent ensheathing glia.

Changes in APPL modify the degenerative phenotype of the dBACE knockdown

The non-autonomous effect of the GMR-GAL4-mediated knockdown of dBACE suggested that dBACE cleaves a substrate that is expressed in photoreceptors but is required for the integrity of the lamina glia. APP proteins are well-known substrates of BACE, and we recently confirmed that fly dBACE does cleave fly APPL (Carmine-Simmen et al., 2009). In addition, we showed that both proteins are expressed in photoreceptors (Fig.7D, E). It has been shown that (as with vertebrate APP) the N-terminus of APPL can be secreted (Luo et al., 1990). We therefore investigated whether APPL, and especially its secreted fragments, are required for glial survival. To address this issue, we co-expressed constructs encoding the soluble N-terminal fragment of APPL (sAPPL, which contains the N-terminus up to aa 758; Wentzell et al. 2012) or the intracellular domain of APPL (dAICD, Wentzell et al. 2012) with the dBACERNAi construct in the eye. To control for effects caused by the introduction of a second UAS construct, we again used UAS-GFP co-expression for comparison (Fig. 8A). However, neither of these APPL fragments had an effect on the degenerative phenotype observed in 4-week-old GMR-GAL4; UAS-dBACERNAi flies, nor did they induce a phenotype when expressed alone (data not shown). Next, we tested co-expression of full-length APPL with the RNAi knockdown and although it did not increase the degenerative phenotype in general (Fig. 8E, left panel), we could now occasionally detect small vacuoles in the lamina neuropil (arrow, Fig. 8B, left panel). In addition, we also detected some vacuoles in the cortex of 4-week-old flies that only expressed UAS-APPL via GMR-GAL4 (arrowheads, Fig. 8B, right panel), however, this increase in vacuolization was not significant when compared to the GFP control (Fig. 8E, right panel). In contrast, flies lacking APPL (Appld) exhibited a significant suppression of the dBACE knockdown phenotype with about half of the flies not showing any signs of degeneration and the other half showing only a few vacuoles (arrowhead, Fig. 8C, left panel). The suppressing effect of Appld was quite surprising, because we recently showed that lacking APPL can induce a degenerative phenotype in aged flies, most likely due to the loss of the protective α-cleaved N-terminal fragment (Wentzell et al., 2012). Although we confirmed degeneration in the lamina cortex of Appld flies (Fig. 8C,E), we nevertheless detected a substantial reduction in the degeneration caused by the dBACE knockdown. This suggested that the phenotype observed in dBACE mutants could be due to an increase in unprocessed full-length APPL and not to the loss of a cleavage product of APPL. To test this hypothesis, we used an APPL construct that carried a deletion in the N-terminal cleavage sites (UAS-APPLSD), so that no secreted fragments can be produced (Torroja et al., 1999). Co-expression of this secretion-deficient construct with UAS-dBACERNAi indeed caused a dramatic enhancement of the vacuolization in 4-week-old animals (Fig. 8C, left panel). Moreover, induction of this construct alone caused degeneration in the lamina cortex (Fig. D, right panel), showing that the an increase in uncleaved APPL can lead to degeneration. Expression of the secretion-deficient APPL construct in the dBACE knockdown further enhanced the degenerative phenotype because in addition to the secretion-deficient APPL less of the endogenous APPL is processed due to the loss of dBACE. To confirm that the loss of dBACE increased the levels of uncleaved APPL, we performed Western Blots using an anti-APPL antibody. Because we did not expect to see a detectable difference in the levels of endogenous APPL, which is expressed in all neurons, when dBACE was only knocked down in photoreceptors, we induced a pan-neuronal knockdown via Appl-GAL4 for this experiment. Although the difference was small, we detected a 1.34 fold increase in full-length APPL in the dBACE knockdown compared to controls (Fig. 9A; mean from three blots; the levels were normalized to the tubulin loading controls).

Figure 8
APPL levels modify the degenerative phenotype. (A) Expressing UAS-GFP in GMRGAL4; UAS-dBACERNAi flies does not alter the degenerative phenotype (left panel) nor does GFP expression alone cause a phenotype (right panel). (B) Co-expression of full-length ...
Figure 9
dBACE knockdown in neurons suppresses APPL-induced phenotypes. (A) A Western Blot using an anti-APPL serum against the intracellular domain reveals increased levels of the endogenous full-length APPL protein in dBACE knockdown flies compared to controls. ...

Loss of dBACE reduces APPL processing and suppresses APPL-induced phenotypes

To confirm that the knockdown of dBACE reduced the β-processing of APPL, we performed Western Blots using antisera against the C-terminus of APPL. Because the endogenous amount of the ß-CTF is very low, we expressed additional APPL via GMR-GAL4 to increase it to detectable levels. As shown in figure 9B (lane 1), we could detect the stronger α-CTF (14.5 kD) as well as the weaker 14 kD ß-CTF band (arrow). Decreasing dBACE via the RNAi construct reduced the levels of the ß-CTF to about 40-50% (Fig. 9B, lane 2), similar to the reduction seen in the heterozygous dBACE5243 mutant (lane 3). In contrast, the production of the α-CTF is increased in both cases. This result confirmed that the knockdown of dBACE did indeed reduce β-processing of APPL.

We also performed a behavioral analysis using the fast phototaxis assay to determine the general mobility and orientation abilities of these flies. As described previously in Carmine-Simmen et al. (2009), overexpression of APPL resulted in behavioral deficits that were enhanced by dBACE co-expression, presumably due to the increased production of the deleterious dAß fragment. Expressing UAS-APPL pan-neuronally with elav-GAL4 caused an age-dependent decline in their performance index (Fig. 9C), confirming our previous results. However, decreasing dBACE levels in these flies by crossing them to dBACE5243 resulted in a dramatic increase in the performance index (PI) that was indistinguishable from wild type flies. This suppression was already detectable in 3-day-old flies (p<0.01) and became even more prominent with aging (Fig. 9C). Notably, we also observed an increase in the survival of flies heterozygous for dBACE5243. Whereas only 23.4% of the elav-GAL4;UAS-APPL flies were alive after 20d, the survival rate of elav-GAL4; UAS-APPL; dBACE5243 was 87.2% (Fig. 9D). These results confirmed that a reduction in dBACE levels, and the corresponding decrease in β-processing of APPL, has the expected beneficial effects on APPL-induced neurotoxic phenotypes.


Originally, BACE1 knockouts in mice were described as quite normal, providing a strong rational that BACE inhibitors could provide a treatment for Alzheimer's Disease. However, subsequently it has been shown that these mice show defects in myelination and synaptic activity (Wang et al., 2008; Vassar et al., 2009; Willem et al., 2009; Kim et al., 2010), showing that BACE1 has important physiological functions. Here we have shown, that the loss of dBACE in Drosophila results in late larval/early pupal lethality, revealing that dBACE is an essential gene in flies. This was confirmed by the lethality of a missense mutation (dBACE5243), either in homozygous flies or when in trans to deficiencies that uncover the dBACE gene. In contrast to flies, BACE1 knockouts in mice are not lethal (Cai et al., 2001), which could be due to the existence of a second BACE (BACE2) protein in mammals and a possible redundancy in their function. Indeed, dBACE is equally similar to BACE1 and BACE2 and could therefore fulfill the role of both vertebrate proteins. Alternatively, dBACE might have additional functions in flies which are required for survival. The lethality induced by the ubiquitous knockdown of dBACE but not the pan-neuronal knockdown, suggests that it is due to a function of dBACE outside the nervous system. In fact, dBACE expression is highest in the midgut (, and the loss of dBACE in this tissue could lead to the larval/early pupal lethality. Because APPL is not expressed outside the nervous system, this lethality would presumably be due to the effects of dBACE on another substrate. As mentioned in the introduction, several other substrates of BACE1 have been identified in vertebrates, but so far no other targets are known in flies.

In contrast to the dBACE5243 allele, dBACE2045 and dBACE2525 were not lethal, and are therefore most likely hypomorphic alleles. This is in agreement with the result that these alleles showed no significant changes in the expression levels of dBACE, suggesting that both point mutations affect the function of the protein. Both of these mutants showed degeneration in the lamina when aged, although the phenotype is weaker in dBACE2525 flies compared to dBACE2045, indicating that dBACE2525 is a weaker hypomorph. A comparable phenotype was seen following both the pan-neuronal and eye-specific knockdown of dBACE, which in the latter becomes first visible (at the light microscopic level) at 14d of age with small vacuoles forming in the lamina cortex that increase with further aging. This showed that dBACE has a non-autonomous effect, however, because the vacuoles only formed in the lamina cortex and no other areas of the brain it suggested a short-range effect. Due to the function of dBACE as a protease, we assumed that this non-autonomous function is mediated via the cleavage of a substrate and the release of a soluble fragment. Indeed, we showed that the degenerative phenotype could be altered by manipulating APPL. Surprisingly, however, expression of the soluble APPL fragment did not suppress the phenotype, but removing endogenous APPL did. Although some vacuoles remained in these flies, the level of vacuolization was similar to the levels of the control Appld flies (1.750% versus 1.826% in the controls), suggesting that removing APPL completely suppressed the dBACE-induced glial degeneration. Together with the result that the secretion-deficient form of APPL had a strong enhancing effect and could induce degeneration in the lamina cortex by itself, this suggest that an excess of uncleaved, full-length APPL causes the glial death. Currently, we do not know whether this effect is due to a direct interaction of APPL with a glial protein or an indirect effect, although a direct cell-cell contact via APPL would be in agreement with the observed short-range effect.

That only glial cells require dBACE activity for survival was supported by the unchanged staining pattern of the pan-neuronal ELAV protein and the presence of monopolar cell bodies in EM preparations from dBACE knockdown flies. However, though not significant, we did see a reduction in the number of monopolar cells in 3-week-old dBACE knockdown flies, which we assume was a secondary effect caused by the loss of glial support. In contrast, the glial staining revealed an age-dependent decrease of REPO-positive cells in these flies, and we also found that glial cells underwent apoptotic cell death, whereas we did not observe apoptotic death of neurons. The population of apoptotic cells included glia in the subretinal layer, and as the EM studies showed, this is also the first region that is affected by the knockdown. This indicates that the fenestrated and pseudocartridge glia that are localized in this layer are the first cells to degenerate. This could be due to a higher sensitivity of these glial cells or to the closer proximity of these cells to the retina. In contrast to the effects of knocking down dBACE selectively in the retina, the point mutations and the pan-neuronal knockdown have a more widespread effect with vacuoles in the lamina neuropil and even in the central parts of the brain. As our immunohistochemical studies show, dBACE and APPL are expressed in most or all neurons, and therefore glia in other parts of the brain might also depend on β-cleavage of APPL for survival. Unfortunately, the glia in other parts of the brain is quite sparse and not arranged in a pattern that would easily allow us to detect a few missing cells; therefore our REPO-stainings were inconclusive.

However, a decrease in dBACE can also have a positive effect, because it significantly improves the behavior and survival of APPL overexpressing flies. We previously showed that overexpression of APPL, dBACE, or the fly dAβ fragment in neurons induces behavioral deficits (Carmine-Simmen et al., 2009), all manipulations that increase dAβ levels. Consequently, decreasing β-processing and therefore dAβ should have a protective effect. In addition, we recently showed that increasing α-processing has a neuroprotective effect (Wentzell et al., 2012). Therefore, the suppression of the APPL–induced phenotypes by dBACE reduction could result from a combined effect of both, the increased α-processing and the decreased β-processing.

To the best of our knowledge a role of APP proteins in glial survival has not been described so far; however, APP, and more specifically its secreted N-terminal fragments, have been implicated in glial differentiation (Kwak et al., 2006; Vrotsos et al., 2009; Kwak et al., 2011). N-terminal fragments of APP have been shown to have a proliferative or neurotrophic function in cell culture, whereby the β-cleaved fragment might be less effective or even deleterious (Li et al., 1997). In addition, it has been published that β-cleavage can result in an APP N-terminal fragment that binds to the DR6 death receptor after trophic factor deprivation of cultured sensory neurons, triggering neuronal death (Nikolaev et al., 2009). In contrast, our results show for the first time a role of β-cleavage in cell survival, which in addition is not mediated by the cleaved ectodomain but by the removal of the full-length protein.


We are very grateful to Roland Strauss (Universitaet Mainz, Germany) for his support of T.T. Many thanks are also due to the OHSU imaging facility, which is supported by the NIH P30NS061800 grant. This work was supported by grants to D.K. from the Medical Research Foundation of Oregon and the Oregon Tax Check-off Program for Alzheimer's Research. B.B. was supported by training grants from the NIH (5T32AG023477, 5T32HD049309) and the Oregon Tax Check-off Program for Alzheimer's Research.


No conflicts of interest


  • Bennett BD, Babu-Khan S, Loeloff R, Louis JC, Curran E, Citron M, Vassar R. Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem. 2000;275:20647–20651. [PubMed]
  • Benzer S. Behavioral mutants of Drosophila isolated by countercurrent distripution. Proc Natl Acad Sci U S A. 1967;58:1112–1119. [PubMed]
  • Bettencourt da Cruz A, Schwarzel M, Schulze S, Niyyati M, Heisenberg M, Kretzschmar D. Disruption of the MAP1B-related protein FUTSCH leads to changes in the neuronal cytoskeleton, axonal transport defects, and progressive neurodegeneration in Drosophila. Mol Biol Cell. 2005;16:2433–2442. [PMC free article] [PubMed]
  • Bogart K, Andrews J. Extraction of Total RNA from Drosophila. CGB Technical Report 10. 2006
  • Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci. 2001;4:233–234. [PubMed]
  • Carmine-Simmen K, Proctor T, Tschape J, Poeck B, Triphan T, Strauss R, Kretzschmar D. Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function. Neurobiol Dis. 2009;33:274–281. [PubMed]
  • Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S, Serneels L, Camacho IE, Marjaux E, Craessaerts K, Roebroek AJ, Schwake M, D'Hooge R, Bach P, Kalinke U, Moechars D, Alzheimer C, Reiss K, Saftig P, De Strooper B. Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J Biol Chem. 2005;280:30797–30806. [PubMed]
  • Drobysheva D, Ameel K, Welch B, Ellison E, Chaichana K, Hoang B, Sharma S, Neckameyer W, Srinakevitch I, Murphy KJ, Schmid A. An optimized method for histological detection of dopaminergic neurons in Drosophila melanogaster. J Histochem Cytochem. 2008;56:1049–1063. [PubMed]
  • Edwards TN, Meinertzhagen IA. The functional organisation of glia in the adult brain of Drosophila and other insects. Prog Neurobiol. 2010;90:471–497. [PMC free article] [PubMed]
  • Fluhrer R, Capell A, Westmeyer G, Willem M, Hartung B, Condron MM, Teplow DB, Haass C, Walter J. A non-amyloidogenic function of BACE-2 in the secretory pathway. J Neurochem. 2002;81:1011–1020. [PubMed]
  • Harrison SM, Harper AJ, Hawkins J, Duddy G, Grau E, Pugh PL, Winter PH, Shilliam CS, Hughes ZA, Dawson LA, Gonzalez MI, Upton N, Pangalos MN, Dingwall C. BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes. Mol Cell Neurosci. 2003;24:646–655. [PubMed]
  • Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci. 2006;9:1520–1525. [PubMed]
  • Hu X, Zhou X, He W, Yang J, Xiong W, Wong P, Wilson CG, Yan R. BACE1 deficiency causes altered neuronal activity and neurodegeneration. J Neurosci. 2010;30:8819–8829. [PMC free article] [PubMed]
  • Hummel T, Krukkert K, Roos J, Davis G, Klambt C. Drosophila Futsch/22C10 is a MAP1B-like protein required for dendritic and axonal development. Neuron. 2000;26:357–370. [PubMed]
  • Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith TS, Simmons DL, Walsh FS, Dingwall C, Christie G. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci. 1999;14:419–427. [PubMed]
  • Kim DY, Gersbacher MT, Inquimbert P, Kovacs DM. Reduced sodium channel Na(v)1.1 levels in BACE1-null mice. J Biol Chem. 2010;286:8106–8116. [PubMed]
  • Kretzschmar D, Pflugfelder GO. Glia in development, function, and neurodegeneration of the adult insect brain. Brain Res Bull. 2002;57:121–131. [PubMed]
  • Kretzschmar D, Hasan G, Sharma S, Heisenberg M, Benzer S. The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J Neurosci. 1997;17:7425–7432. [PubMed]
  • Kwak YD, Marutle A, Dantuma E, Merchant S, Bushnev S, Sugaya K. Involvement of notch signaling pathway in amyloid precursor protein induced glial differentiation. Eur J Pharmacol. 2011;650:18–27. [PMC free article] [PubMed]
  • Kwak YD, Brannen CL, Qu T, Kim HM, Dong X, Soba P, Majumdar A, Kaplan A, Beyreuther K, Sugaya K. Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev. 2006;15:381–389. [PubMed]
  • Laird FM, Cai H, Savonenko AV, Farah MH, He K, Melnikova T, Wen H, Chiang HC, Xu G, Koliatsos VE, Borchelt DR, Price DL, Lee HK, Wong PC. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci. 2005;25:11693–11709. [PMC free article] [PubMed]
  • Li HL, Roch JM, Sundsmo M, Otero D, Sisodia S, Thomas R, Saitoh T. Defective neurite extension is caused by a mutation in amyloid beta/A4 (A beta) protein precursor found in familial Alzheimer's disease. J Neurobiol. 1997;32:469–480. [PubMed]
  • Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci U S A. 2000;97:1456–1460. [PubMed]
  • Luo LQ, Martin-Morris LE, White K. Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor. J Neurosci. 1990;10:3849–3861. [PubMed]
  • Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, Kha H, Zhang J, Gong Y, Martin L, Louis JC, Yan Q, Richards WG, Citron M, Vassar R. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci. 2001;4:231–232. [PubMed]
  • McGraw LA, Gibson G, Clark AG, Wolfner MF. Genes regulated by mating, sperm, or seminal proteins in mated female Drosophila melanogaster. Curr Biol. 2004;14:1509–1514. [PubMed]
  • Mowrer KR, Wolfe MS. Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production. J Biol Chem. 2008;283:18694–18701. [PubMed]
  • Ohno M, Cole SL, Yasvoina M, Zhao J, Citron M, Berry R, Disterhoft JF, Vassar R. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol Dis. 2007;26:134–145. [PMC free article] [PubMed]
  • Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45. [PMC free article] [PubMed]
  • Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, Freedman SB, Frigon NL, Games D, Hu K, Johnson-Wood K, Kappenman KE, Kawabe TT, Kola I, Kuehn R, Lee M, Liu W, Motter R, Nichols NF, Power M, Robertson DW, Schenk D, Schoor M, Shopp GM, Shuck ME, Sinha S, Svensson KA, Tatsuno G, Tintrup H, Wijsman J, Wright S, McConlogue L. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet. 2001;10:1317–1324. [PubMed]
  • Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomensaari SM, Wang S, Walker D, Zhao J, McConlogue L, John V. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 1999;402:537–540. [PubMed]
  • Strauss R, Heisenberg M. A higher control center of locomotor behavior in the Drosophila brain. J Neurosci. 1993;13:1852–1861. [PubMed]
  • Torroja L, Packard M, Gorczyca M, White K, Budnik V. The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J Neurosci. 1999;19:7793–7803. [PubMed]
  • Vassar R, Kovacs DM, Yan R, Wong PC. The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci. 2009;29:12787–12794. [PMC free article] [PubMed]
  • Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286:735–741. [PubMed]
  • Vrotsos EG, Kolattukudy PE, Sugaya K. MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling. Brain Res Bull. 2009;79:97–103. [PMC free article] [PubMed]
  • Wang H, Song L, Laird F, Wong PC, Lee HK. BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J Neurosci. 2008;28:8677–8681. [PMC free article] [PubMed]
  • Wentzell JS, Bolkan BJ, Carmine-Simmen K, Swanson TL, Musashe DT, Kretzschmar D. Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration. Neurobiol Dis. 2012;46:78–87. [PubMed]
  • Willem M, Lammich S, Haass C. Function, regulation and therapeutic properties of beta-secretase (BACE1) Semin Cell Dev Biol. 2009;20:175–182. [PubMed]
  • Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, DeStrooper B, Saftig P, Birchmeier C, Haass C. Control of peripheral nerve myelination by the beta-secretase BACE1. Science. 2006;314:664–666. [PubMed]
  • Winkler S, Schwabedissen A, Backasch D, Bokel C, Seidel C, Bonisch S, Furthauer M, Kuhrs A, Cobreros L, Brand M, Gonzalez-Gaitan M. Target-selected mutant screen by TILLING in Drosophila. Genome Res. 2005;15:718–723. [PubMed]
  • Yan R, Munzner JB, Shuck ME, Bienkowski MJ. BACE2 functions as an alternative alpha-secretase in cells. J Biol Chem. 2001;276:34019–34027. [PubMed]
  • Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 1999;402:533–537. [PubMed]